Lasa Supergenerics Limited
LASA.BOLasa Supergenerics Limited in brief
Lasa Supergenerics Limited is a listed company in the Pharmaceutical industry, based in India. Its market value was $2 M on 16 November 2026, which makes it the 27,671st largest listed company in the world and the 3,075th largest in India on this site. Its shares trade under the symbol LASA.BO (BSE).
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
Lasa Supergenerics Limited timeline
- 2017
- ๐Listed on National Stock Exchange of India as LASAFirst day of listing in the exchange's official list.
Events of Lasa Supergenerics Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Lasa Supergenerics Limited share price ยท NSE (LASA.NS)
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | 4.130 | 4.130 | 4.010 | 4.010 | -5.0% | 49,949 |
| Nov 9, 2026 | 4.440 | 4.440 | 4.220 | 4.220 | -5.0% | 71,016 |
| Nov 2, 2026 | 4.440 | 4.650 | 4.440 | 4.440 | -4.9% | 53,166 |
| Oct 26, 2026 | 4.860 | 4.860 | 4.670 | 4.670 | -4.9% | 42,091 |
| Oct 19, 2026 | 5.160 | 5.390 | 4.910 | 4.910 | -4.8% | 37,588 |
| Oct 12, 2026 | 5.060 | 5.580 | 5.060 | 5.160 | -3.0% | 166,935 |
| Oct 5, 2026 | 5.320 | 5.320 | 5.320 | 5.320 | -5.0% | 59,554 |
| Sep 28, 2026 | 5.600 | 5.600 | 5.600 | 5.600 | -4.9% | 21,802 |
| Sep 21, 2026 | 5.890 | 5.890 | 5.890 | 5.890 | -5.0% | 17,769 |
| Sep 15, 2026 | 6.200 | 6.200 | 6.200 | 6.200 | -4.9% | 18,314 |
| Sep 9, 2026 | 6.710 | 6.710 | 6.450 | 6.520 | -2.5% | 46,913 |
| Sep 8, 2026 | 6.700 | 6.830 | 6.650 | 6.690 | +0.1% | 35,670 |
| Sep 7, 2026 | 6.730 | 6.800 | 6.600 | 6.680 | -0.7% | 17,590 |
| Sep 4, 2026 | 6.990 | 7.000 | 6.690 | 6.730 | -1.3% | 24,575 |
| Sep 3, 2026 | 6.900 | 6.980 | 6.810 | 6.820 | +0.6% | 25,647 |
| Sep 2, 2026 | 6.960 | 6.960 | 6.660 | 6.780 | +0.3% | 20,793 |
| Sep 1, 2026 | 6.920 | 7.040 | 6.700 | 6.760 | -2.3% | 27,177 |
| Aug 31, 2026 | 7.100 | 7.280 | 6.730 | 6.920 | -1.0% | 36,812 |
| Aug 28, 2026 | 7.000 | 7.420 | 6.850 | 6.990 | +0.3% | 69,589 |
| Aug 27, 2026 | 7.200 | 7.200 | 6.830 | 6.970 | +0.4% | 16,622 |
| Aug 26, 2026 | 7.210 | 7.210 | 6.870 | 6.940 | -1.8% | 20,756 |
| Aug 25, 2026 | 7.050 | 7.500 | 6.760 | 7.070 | -2.6% | 32,176 |
| Aug 24, 2026 | 7.380 | 7.380 | 7.050 | 7.260 | +0.8% | 25,439 |
| Aug 21, 2026 | 6.990 | 7.500 | 6.600 | 7.200 | +3.0% | 37,768 |
| Aug 20, 2026 | 7.230 | 7.330 | 6.420 | 6.990 | -1.4% | 87,284 |
| Aug 19, 2026 | 7.210 | 7.400 | 6.950 | 7.090 | -1.4% | 21,874 |
| Aug 18, 2026 | 7.140 | 7.440 | 6.750 | 7.190 | +0.7% | 25,232 |
| Aug 17, 2026 | 7.560 | 7.560 | 7.070 | 7.140 | -3.6% | 26,290 |
| Aug 14, 2026 | 7.490 | 7.550 | 7.250 | 7.410 | -1.5% | 10,223 |
| Aug 13, 2026 | 7.150 | 7.750 | 7.150 | 7.520 | โ | 25,454 |
Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Lasa Supergenerics Limited share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in India: #1,397 (Jan 2020) ยท #1,007 (Jan 2021) ยท #1,454 (Jan 2022) ยท #1,788 (Dec 2022) ยท #1,912 (Jul 2023) ยท #1,544 (Jan 2024) ยท #2,237 (Mar 2026) ยท #3,059 (Nov 2026)
How Lasa Supergenerics Limited compares in Pharmaceutical
- Market cap$2 M ยท higher than 2% of 395
Peer comparison ยท Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Lasa Supergenerics Limited๐ฎ๐ณ | $2 M | โ | โ | โ |
| Eli Lilly and Company๐บ๐ธ | $1.20 T | 43.4ร | 31.9% | +44.7% |
| Johnson & Johnson๐บ๐ธ | $652.5 B | 40.5ร | 16.2% | +6.0% |
| AbbVie Inc.๐บ๐ธ | $514.0 B | 49.7ร | 15.7% | +8.6% |
| Roche Holding AG๐จ๐ญ | $370.3 B | 29.1ร | 19.0% | โ |
| Merck & Co., Inc.๐บ๐ธ | $359.8 B | 146.7ร | 3.6% | +1.3% |
| Novartis AG๐จ๐ญ | $286.8 B | 20.5ร | 24.7% | โ |
| Amgen Inc.๐บ๐ธ | $249.2 B | 26.5ร | 24.1% | +9.9% |
| AstraZeneca PLC๐ฌ๐ง | $242.6 B | 23.7ร | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
How current the figures are
- Market cap:
- Nov 16, 2026
- Profile updated:
- Nov 22, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Lasa Supergenerics Limited? Verify and update this profile โ free
Show Lasa Supergenerics Limited's ranking on your website Get the badge
The badge updates itself as the ranking changes.